These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21529614)

  • 1. The effect of HPβCD on Cyclosporine A in-vitro release from PLGA nanoparticles.
    Hermans K; Weyenberg W; Ludwig A
    J Control Release; 2010 Nov; 148(1):e40-1. PubMed ID: 21529614
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative evaluation of cyclosporine A/HPβCD-incorporated PLGA nanoparticles for development of effective ocular preparations.
    Aksungur P; Demirbilek M; Denkbaş EB; Unlü N
    J Microencapsul; 2012; 29(6):605-13. PubMed ID: 22432850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-beta-cyclodextrin system.
    De Rosa G; Larobina D; Immacolata La Rotonda M; Musto P; Quaglia F; Ungaro F
    J Control Release; 2005 Jan; 102(1):71-83. PubMed ID: 15653135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity and anti-inflammatory activity of cyclosporine A loaded PLGA nanoparticles for ocular use.
    Hermans K; Van Den Plas D; Schreurs E; Weyenberg W; Ludwig A
    Pharmazie; 2014 Jan; 69(1):32-7. PubMed ID: 24601220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes.
    Cheng FY; Wang SP; Su CH; Tsai TL; Wu PC; Shieh DB; Chen JH; Hsieh PC; Yeh CS
    Biomaterials; 2008 May; 29(13):2104-12. PubMed ID: 18276001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles.
    He W; Horn SW; Hussain MD
    Int J Pharm; 2007 Apr; 334(1-2):173-8. PubMed ID: 17101249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
    Yin Y; Chen D; Qiao M; Lu Z; Hu H
    J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles.
    Kadari A; Gudem S; Kulhari H; Bhandi MM; Borkar RM; Kolapalli VR; Sistla R
    Drug Deliv; 2017 Nov; 24(1):224-232. PubMed ID: 28156161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vectorization of copper complexes via biocompatible and biodegradable PLGA nanoparticles.
    Courant T; Roullin VG; Cadiou C; Delavoie F; Molinari M; Andry MC; Gafa V; Chuburu F
    Nanotechnology; 2010 Apr; 21(16):165101. PubMed ID: 20348590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles.
    Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W
    Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a new delivery system consisting in 'drug-in cyclodextrin-in PLGA nanoparticles'.
    Mura P; Maestrelli F; Cecchi M; Bragagni M; Almeida A
    J Microencapsul; 2010; 27(6):479-86. PubMed ID: 20113170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugates of poly(DL-lactide-co-glycolide) on amino cyclodextrins and their nanoparticles as protein delivery system.
    Gao H; Wang YN; Fan YG; Ma JB
    J Biomed Mater Res A; 2007 Jan; 80(1):111-22. PubMed ID: 16960831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles.
    Glowka E; Sapin-Minet A; Leroy P; Lulek J; Maincent P
    J Microencapsul; 2010; 27(1):25-36. PubMed ID: 19229671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles.
    Ozturk K; Caban S; Kozlu S; Kadayifci E; Yerlikaya F; Capan Y
    Pharmazie; 2010 Sep; 65(9):665-9. PubMed ID: 21038843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of β-cyclodextrin on the internalization of nanoparticles into intestine epithelial cells.
    García-González L; Yépez-Mulía L; Ganem A
    Eur J Pharm Sci; 2016 Jan; 81():113-8. PubMed ID: 26478186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
    Nie H; Wang CH
    J Control Release; 2007 Jul; 120(1-2):111-21. PubMed ID: 17512077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of microfluidization parameters on the physical properties of PEG-PLGA nanoparticles prepared using high pressure microfluidization.
    Sani SN; Das NG; Das SK
    J Microencapsul; 2009 Sep; 26(6):556-61. PubMed ID: 18946802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.